Skip to Content

200 mg GILEAD (Emtriva 200 mg)

Generic Name: emtricitabine

Pill imprint 200 mg GILEAD has been identified as Emtriva 200 mg.

Emtriva is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Emtriva 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Emtriva 200 mg 200 mg GILEAD
Emtriva 200 mg 200 mg GILEAD
Emtriva 200 mg 200 mg GILEAD
Emtriva
Generic Name:
emtricitabine
Imprint:
200 mg GILEAD
Strength:
200 mg
Color:
Blue & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Gilead Sciences
National Drug Code (NDC):
61958-0601
Inactive Ingredients:
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
water
FD&C Blue No. 2
titanium dioxide
gelatin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4853 Physicians Total Care Inc (repackager)
54569-5521 A-S Medication Solutions, LLC (repackager)
35356-0205 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide